Falkon L, Garí M, Borrell M, Fontcuberta J
Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Blood Coagul Fibrinolysis. 1992 Feb;3(1):33-8. doi: 10.1097/00001721-199202000-00006.
The aim of the present study was to compare plasma levels of urokinase-type plasminogen activator (u-PA), before and after 20 min of venous stasis, with those of tissue-type plasminogen activator (t-PA), type 1 plasminogen activator inhibitor (PAI-1) and t-PA/PAI-1 complexes, to determine whether both plasminogen activators and their inhibitor respond similarly to the same stimulus. We studied 36 patients with recurrent venous thrombosis in whom no coagulation defects predisposing them to thrombosis had been detected (mean age 38.2 years, range 15-70 years). Twenty healthy individuals (mean age 34.3 years, range 20-60 years) served as a control group. t-PA, PAI-1 and u-PA activity and antigen, as well as the t-PA/PAI-1 complex antigen, were measured before and after venous stasis. Post-stasis fibrinolytic parameters were corrected for the haemoconcentration which occurred during the venous occlusion test. Pathologically high PAI-1 levels (antigen and activity) were found in four out of 36 patients who were excluded from study. Functional and antigenic u-PA increased significantly after venous stasis when analysed as the absolute differences between paired samples (P less than 0.01). This increase in u-PA did not correlate with changes in t-PA or PAI-1 (r = 0.28 and r = 0.36 respectively). This leads us to suggest that different mechanisms relating to clearance and/or release from diverse sources might be involved in elevations of u-PA in response to a local endothelial stimulus. We conclude that venous stasis might not be the elective choice when evaluating 'bad responders' predisposed to thrombosis.
本研究的目的是比较静脉淤滞20分钟前后血浆中尿激酶型纤溶酶原激活物(u-PA)的水平与组织型纤溶酶原激活物(t-PA)、1型纤溶酶原激活物抑制剂(PAI-1)及t-PA/PAI-1复合物的水平,以确定纤溶酶原激活物及其抑制剂对相同刺激的反应是否相似。我们研究了36例复发性静脉血栓形成患者,这些患者未检测到易导致血栓形成的凝血缺陷(平均年龄38.2岁,范围15 - 70岁)。20名健康个体(平均年龄34.3岁,范围20 - 60岁)作为对照组。在静脉淤滞前后测量t-PA、PAI-1和u-PA的活性及抗原,以及t-PA/PAI-1复合物抗原。对静脉淤滞后纤溶参数进行校正,以消除静脉闭塞试验期间发生的血液浓缩影响。在36例患者中有4例因PAI-1水平(抗原和活性)病理性升高而被排除在研究之外。当以配对样本的绝对差值分析时,静脉淤滞后功能性和抗原性u-PA显著增加(P < 0.01)。u-PA的这种增加与t-PA或PAI-1的变化无关(r分别为0.28和0.36)。这使我们认为,u-PA对局部内皮刺激升高的反应可能涉及与不同来源的清除和/或释放相关的不同机制。我们得出结论,在评估易发生血栓形成的“反应不良者”时,静脉淤滞可能不是首选方法。